The Effect of Local Corticosteroid Injection in Carpal Tunnel Syndrome Patients With Type 2 Diabetes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorHaydarpasa Numune Training and Research Hospital

About this trial

Our study was planned as a prospective observational study aiming to compare the post-intervention recovery process between patients with carpal tunnel syndrome (CTS) and diabetes mellitus and patients with idiopathic carpal tunnel syndrome without diabetes mellitus. Patients who presented to the Physical Medicine and Rehabilitation outpatient clinic with clinical symptoms consistent with carpal tunnel syndrome and who were diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological findings and who received corticosteroid + local anesthetic injection will be included in the study. Data from patients who meet the inclusion and exclusion criteria will be included in the study. Patients' demographic and clinical data will be recorded. Records will be taken before treatment and at 4 and 12 weeks after treatment.

Eligibility criteria

Qualifiers

Age between 18 and 75 years

Presence of clinical symptoms compatible with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months

Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings

Diagnosis of type 2 diabetes mellitus

Disqualifiers

Severe carpal tunnel syndrome based on electrophysiological findings

Presence of polyneuropathy, cervical radiculopathy, brachial plexopathy, or thoracic outlet syndrome

Uncontrolled blood glucose levels in the diabetic group (hemoglobin A1c ≥ 7%)

Presence of another systemic disease, other than diabetes mellitus, that may cause carpal tunnel syndrome

Trial design

Treatments tested in this trial

  • 1 mL 40 mg [40 mg/mL] triamcinolone acetonide + 1 mL 2% lidocaine hydrochloride

Treatment groups

60 Participants
are divided into 2 treatment groups